GeneReach Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	140.13	155.07	110.27	216.77	748.61	663.43
Short-Term Investments	240.22	114	181.01	285.95	-	-
Trading Asset Securities	25.59	20.69	122.7	-	-	-
Cash & Short-Term Investments	405.94	289.76	413.98	502.72	748.61	663.43
Cash Growth	-11.47%	-30.01%	-17.65%	-32.85%	12.84%	111.50%
Accounts Receivable	32.9	39.37	43.05	21.47	55.86	195.75
Other Receivables	2.88	2.16	3.37	1.68	0.4	0.72
Receivables	35.78	41.53	46.42	23.14	56.26	196.47
Inventory	33.38	32.56	37.52	67.37	235.81	268.3
Prepaid Expenses	2.85	1.88	3.24	5.88	8.36	34.68
Other Current Assets	3.47	118.43	93.51	33.01	21.03	17.66
Total Current Assets	481.42	484.16	594.67	632.14	1,070	1,181
Property, Plant & Equipment	271.76	284.73	359.65	433.83	436.93	397.11
Long-Term Investments	3.24	-	-	-	-	3.24
Other Intangible Assets	15.24	15.43	12.4	12.35	9.49	10.03
Long-Term Deferred Tax Assets	81.99	81.78	83.21	77.65	35.26	24
Other Long-Term Assets	10.96	14.95	16.56	20.18	70.15	69.51
Total Assets	864.6	881.05	1,066	1,176	1,622	1,684
Accounts Payable	5.98	7.19	7.74	8.86	13.35	31.68
Short-Term Debt	136	136	171	104	49	49
Current Portion of Long-Term Debt	-	-	-	35.62	204.42	7.5
Current Portion of Leases	11.4	11.4	11.64	11.38	12.64	8.54
Current Income Taxes Payable	-	-	7	3.59	23.08	74.45
Current Unearned Revenue	3.44	3.34	2.93	4.96	7.8	19.43
Other Current Liabilities	34.9	43.2	39.21	37.5	74.8	87.62
Total Current Liabilities	191.72	201.13	239.53	205.9	385.09	278.21
Long-Term Debt	-	-	-	-	15	217.39
Long-Term Leases	68.14	71.7	84.59	97.74	108.89	87.35
Long-Term Unearned Revenue	9.74	9.53	10.57	8.78	8.95	8.82
Pension & Post-Retirement Benefits	-	-	-	-	-	1.73
Long-Term Deferred Tax Liabilities	2.02	1.99	6.29	1.26	1.28	1.2
Other Long-Term Liabilities	-	-	0.02	0.02	0.02	1.64
Total Liabilities	271.62	284.34	341	313.71	519.23	596.35
Common Stock	580.58	580.58	574.58	574.58	459.66	417.87
Additional Paid-In Capital	150.54	150.54	144.9	144.9	144.9	144.9
Retained Earnings	-122.7	-117.32	-3.29	114.74	464.44	491.74
Treasury Stock	-17.31	-17.31	-	-	-	-
Comprehensive Income & Other	-7.56	-9.76	0.79	-2.15	-1.33	-4.7
Total Common Equity	583.55	586.73	716.98	832.06	1,068	1,050
Minority Interest	9.43	9.99	8.51	30.37	35.01	38.26
Shareholders' Equity	592.98	596.72	725.49	862.44	1,103	1,088
Total Liabilities & Equity	864.6	881.05	1,066	1,176	1,622	1,684
Total Debt	215.54	219.1	267.23	248.74	389.95	369.78
Net Cash (Debt)	190.4	70.67	146.75	253.98	358.66	293.65
Net Cash Growth	-2.67%	-51.84%	-42.22%	-29.19%	22.14%	133.48%
Net Cash Per Share	3.31	1.24	2.55	4.42	6.05	5.01
Filing Date Shares Outstanding	59.71	57.3	57.46	57.46	57.46	57.46
Total Common Shares Outstanding	59.71	57.3	57.46	57.46	57.46	57.46
Working Capital	289.7	283.03	355.14	426.24	684.99	902.32
Book Value Per Share	9.77	10.24	12.48	14.48	18.58	18.27
Tangible Book Value	568.32	571.29	704.59	819.72	1,058	1,040
Tangible Book Value Per Share	9.52	9.97	12.26	14.27	18.42	18.10
Buildings	-	296.08	293.85	292.04	267.33	266.03
Machinery	-	306.55	332.71	309.58	273.19	231.16
Construction In Progress	-	0.26	-	-	20.95	-